Our previous studies also found that TGFβRI expression was reduced in the naïve CD4+ T cells of untreated and newly diagnosed SLE patients, which suggested that the abnormal expression of TGFβRI might participate in SLE pathogenesis (13). This evidence concerns the gene CD4 and systemic lupus erythematosus.